comparemela.com
Home
Live Updates
Breakthrough Study Demonstrates that High-Dose Hemodiafiltra
Breakthrough Study Demonstrates that High-Dose Hemodiafiltra
Breakthrough Study Demonstrates that High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality Rates
/PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, participated in...
Related Keywords
London ,
City Of ,
United Kingdom ,
Waltham ,
Leicestershire ,
Berlin ,
Germany ,
Frankfurt ,
Brandenburg ,
Frank Maddux ,
Bryan Jimenez ,
B Braun Avitum ,
Peter Blankestijn ,
Dominik Heger ,
Steffen Rinas ,
Imperial College London ,
Frankfurt Stock Exchange ,
York Stock Exchange ,
Fresenius Medical Care Holdings Inc ,
University Medical Center Utrecht ,
Fresenius Medical Care Ag Co ,
University College London ,
George Institute For Global Health ,
University Of Bari ,
European Commission ,
Fresenius Medical Care ,
European Commission Research Innovation ,
Exchange Commission ,
Medical Care ,
Chief Global Medical Officer ,
Professor Peter Blankestijn ,
George Institute ,
Global Health ,
New York Stock Exchange ,
European Commission Research ,
Medical Care Holdings ,